SECURITIES AND EXCHANGE COMMISSION FORM 8-K

First Page		Document Content
Date: 2012-06-03 08:54:50 Asuragen United States securities law Norwalk Connecticut Information Small interfering RNA Copyright Securities Act Business Technology Applied Biosystems Applera Celera Corporation		SECURITIES AND EXCHANGE COMMISSION FORM 8-K Add to Reading List Source URL: pdf.secdatabase.com Download Document from Source Website File Size: 158,08 KB Share Document on Facebook

	THIS INSTRUMENT HAS BEEN ISSUED PURSUANT TO SECTION 4(A)(6) OF THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND NEITHER IT NOR ANY SECURITIES ISSUABLE PURSUANT HERETO HAVE BEEN REGISTERED UNDER THE DocID: 1xTrz - View Document
	Overview of FY3/2018 performance May 14, 2018 ディスクレーマー This document contains “forward-looking statements” (as defined in the U.S. Private Securities Litigation Reform Act of 1995), regarding the int DocID: 1vqbR - View Document
	UNITED STATES OF AMERICA Before the SECURITIES AND EXCHANGE COMMISSION SECURITIES EXCHANGE ACT OF 1934 Release NoMarch 13, 2018 ACCOUNTING AND AUDITING ENFORCEMENT DocID: 1vq0h - View Document
	CONFLICT MINERALS The following is provided in connection with Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Securities and Exchange Commission Rule 13p-1 and Form SD (17 CFR 240.13p-1 DocID: 1vnAy - View Document
	THIS INSTRUMENT HAS BEEN ISSUED PURSUANT TO SECTION 4(A)(6) OF THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND NEITHER IT NOR ANY SECURITIES ISSUABLE PURSUANT HERETO HAVE BEEN REGISTERED UNDER THE DocID: 1vgsV - View Document